Regorafenib is a synthetic compound studied as an active pharmaceutical ingredient, characterized by an aromatic, halogen-containing structure. Its crystalline forms and monohydrate have been investigated for structural properties relevant to pharmaceutical manufacturing.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 755037-03-7
Regorafenib monohydrate
active pharmaceutical ingredient
Sorafenib
n.a
Tosilate de sorafénib
active pharmaceutical ingredient
Flupirtine maleate
active pharmaceutical ingredient
COLCHICINE, (+)-
active pharmaceutical ingredient
Ingenol mebutate
antineoplastic agent
Fludarabine phosphate
active pharmaceutical ingredient
4-[4-[[[[2-Chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide
Pharmaceutical reference standard intermediate
4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]-3-fluorophenoxy]-N-methylpyridine-2-carboxamide
FNHKPVJBJVTLMP-UHFFFAOYSA-N
CNC(=O)C1=NC=CC(=C1)OC2=CC(=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)F